Testing the Addition of Iberdomide to Therapy in People With Neuroblastoma That Has Come Back, Not Responded to Treatment, or Gotten Worse
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Children's Oncology Group
Roswell Park Cancer Institute
Children's Oncology Group
Memorial Sloan Kettering Cancer Center
New Approaches to Neuroblastoma Therapy Consortium
National Cancer Institute (NCI)
Dana-Farber Cancer Institute
Nationwide Children's Hospital
New Approaches to Neuroblastoma Therapy Consortium
Epitopoietic Research Corporation
Case Comprehensive Cancer Center
Fundació Sant Joan de Déu
Duke University
National Cancer Institute (NCI)
University of California, San Francisco
Baylor College of Medicine
Children's Oncology Group
University of Texas Southwestern Medical Center
Immatics Biotechnologies GmbH
Celldex Therapeutics
Celldex Therapeutics
St. Jude Children's Research Hospital
Masonic Cancer Center, University of Minnesota
Children's Oncology Group
Roswell Park Cancer Institute
Duke University
Cancer Research UK
SWOG Cancer Research Network
Children's Oncology Group
Children's Oncology Group
National Cancer Institute (NCI)
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)
Barbara Ann Karmanos Cancer Institute
Barbara Ann Karmanos Cancer Institute
National Cancer Institute (NCI)
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)
Dana-Farber Cancer Institute
Case Comprehensive Cancer Center